Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
BackgroundThe rapidly expanding clinical adaptation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has placed an increasing onus on understanding both the potential pearls of interpretation as well as limitations of this new techn...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 August 2017
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2017, Jahrgang: 44, Heft: 12, Pages: 2117-2136 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-017-3780-7 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00259-017-3780-7 Verlag, Volltext: https://link.springer.com/article/10.1007/s00259-017-3780-7 
|
| Verfasserangaben: | Sara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, Lilja B. Solnes, Mehrbod S. Javadi, Ashley E. Ross, Kenneth J. Pienta, Mohamad E. Allaf, Uwe Haberkorn, Martin G. Pomper, Michael A. Gorin, Steven P. Rowe |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1578165601 | ||
| 003 | DE-627 | ||
| 005 | 20230426230820.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180801s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-017-3780-7 |2 doi | |
| 035 | |a (DE-627)1578165601 | ||
| 035 | |a (DE-576)508165601 | ||
| 035 | |a (DE-599)BSZ508165601 | ||
| 035 | |a (OCoLC)1341015312 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Sheikhbahaei, Sara |e VerfasserIn |0 (DE-588)1163688797 |0 (DE-627)1028065531 |0 (DE-576)508165067 |4 aut | |
| 245 | 1 | 0 | |a Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging |c Sara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, Lilja B. Solnes, Mehrbod S. Javadi, Ashley E. Ross, Kenneth J. Pienta, Mohamad E. Allaf, Uwe Haberkorn, Martin G. Pomper, Michael A. Gorin, Steven P. Rowe |
| 264 | 1 | |c 1 August 2017 | |
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 1 August 2017 | ||
| 500 | |a Gesehen am 01.08.2018 | ||
| 520 | |a BackgroundThe rapidly expanding clinical adaptation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has placed an increasing onus on understanding both the potential pearls of interpretation as well as limitations of this new technique. As with any new molecular imaging modality, accurate characterization of abnormalities on PSMA-targeted PET imaging can be accomplished only if one is aware of the normal distribution pattern, physiological variants of radiotracer uptake, and potential sources of false-positive and false-negative imaging findings. In recent years, a growing number of reports have come to light describing incidental non-prostatic benign or malignant pathologies with high uptake on PSMA-targeted PET imaging. In this review, we have summarized the published literature regarding the potential pearls and technical and interpretive pitfalls of this imaging modality. Knowledge of these limitations can increase the confidence of interpreting physicians and thus improve patient care.ConclusionsAs PSMA-targeted PET is expected to be evaluated in larger prospective trials, the dissemination of potential diagnostic pitfalls and the biologic underpinning of those findings will be of increased importance. | ||
| 700 | 1 | |a Afshar-Oromieh, Ali |d 1975- |e VerfasserIn |0 (DE-588)130260436 |0 (DE-627)496579711 |0 (DE-576)189580003 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 44(2017), 12, Seite 2117-2136 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging |
| 773 | 1 | 8 | |g volume:44 |g year:2017 |g number:12 |g pages:2117-2136 |g extent:20 |a Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00259-017-3780-7 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00259-017-3780-7 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180801 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 9 | ||
| 998 | |g 130260436 |a Afshar-Oromieh, Ali |m 130260436:Afshar-Oromieh, Ali |p 2 | ||
| 999 | |a KXP-PPN1578165601 |e 3020043158 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1578165601"],"doi":["10.1007/s00259-017-3780-7"]},"physDesc":[{"extent":"20 S."}],"relHost":[{"part":{"extent":"20","issue":"12","year":"2017","pages":"2117-2136","text":"44(2017), 12, Seite 2117-2136","volume":"44"},"id":{"zdb":["2098375-X"],"issn":["1619-7089"],"eki":["359787258"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"origin":[{"publisherPlace":"Heidelberg [u.a.]","dateIssuedKey":"2002","dateIssuedDisp":"2002-","publisher":"Springer-Verl."}],"title":[{"subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title_sort":"European journal of nuclear medicine and molecular imaging","title":"European journal of nuclear medicine and molecular imaging"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["29.2002 -"],"disp":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingEuropean journal of nuclear medicine and molecular imaging","recId":"359787258","language":["eng"]}],"note":["Published online: 1 August 2017","Gesehen am 01.08.2018"],"recId":"1578165601","origin":[{"dateIssuedDisp":"1 August 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Sara Sheikhbahaei, Ali Afshar-Oromieh, Matthias Eiber, Lilja B. Solnes, Mehrbod S. Javadi, Ashley E. Ross, Kenneth J. Pienta, Mohamad E. Allaf, Uwe Haberkorn, Martin G. Pomper, Michael A. Gorin, Steven P. Rowe"]},"person":[{"family":"Sheikhbahaei","display":"Sheikhbahaei, Sara","given":"Sara","role":"aut"},{"role":"aut","display":"Afshar-Oromieh, Ali","given":"Ali","family":"Afshar-Oromieh"},{"display":"Haberkorn, Uwe","given":"Uwe","family":"Haberkorn","role":"aut"}],"language":["eng"],"title":[{"title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","title_sort":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging"}]} | ||
| SRT | |a SHEIKHBAHAPEARLSANDP1201 | ||